跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/NCT01903213
NCT01903213已完成不适用

Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis

Astellas Pharma Inc0 个研究点目标入组 123 人开始时间: 2013年3月19日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
123
主要终点
Safety assessed by the incidence of adverse events (including adverse drug reactions), vital signs and laboratory tests
研究概览研究设计入排标准研究组 & 干预措施结局指标研究者记录与标识符相似试验

研究概览

简要总结

To evaluate the safety and efficacy of long-term use of Kiklin® Capsules in actual clinical settings.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Chronic renal failure patients with Hyperphosphatemia receiving peritoneal dialysis

排除标准

  • 未提供

研究组 & 干预措施

Kiklin group

Oral

干预措施: bixalomer (Drug)

结局指标

主要结局

Safety assessed by the incidence of adverse events (including adverse drug reactions), vital signs and laboratory tests

时间窗: Baseline and 1, 2, 3, 6, 12 months after administration

次要结局

  • Serum phosphorous levels(Baseline and 1, 2, 3, 6, 12 months after administration)
  • Serum calcium level(Baseline and 1, 2, 3, 6, 12 months after administration)
  • Serum albumin level(Baseline and 1, 2, 3, 6, 12 months after administration)
  • Serum intact PTH (parathyroid hormone) level(Baseline and 1, 2, 3, 6, 12 months after administration)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

已完成
不适用
Post-marketing Surveillance of Kiklin Capsules in Hemodialysis PatientsChronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis
NCT01901107Astellas Pharma Inc1,078
已完成
不适用
EFFEKT - Efficacy and Safety of Long-term Treatment With KOGENATE Bayer/FSHemophilia A
NCT00874926Bayer405
已完成
不适用
Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in JapanLung Diseases, Interstitial
NCT04325217Boehringer Ingelheim586
已完成
不适用
Post Marketing Surveillance Study To Observe Safety And Efficacy Of SuteneGastrointestinal Stromal Tumors
NCT00444795Pfizer520
已完成
不适用
Post Marketing Surveillance on Long-term Use With Norditropin® (Short Stature Due to Noonan Syndrome)Noonan SyndromeGenetic Disorder
NCT03435627Novo Nordisk A/S71
Post-Marketing Surveillance on Long-Term Drug Use of... | 临床试验